Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter Randomized Trial of Chlorambucil Versus Chlorambucil Plus Rituximab Versus Rituximab in Extranodal Marginal Zone B-cell Lymphoma of Mucosa Associated Lymphoid Tissue (MALT Lymphoma)

NCT00210353 is registered in ClinicalTrials.gov with International Extranodal Lymphoma Study Group (IELSG) as lead sponsor.

NCT NCT00210353
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00210353 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter Randomized Trial of Chlorambucil Versus Chlorambucil Plus Rituximab Versus Rituximab in Extranodal Marginal Zone B-cell Lymphoma of Mucosa Associated Lymphoid Tissue (MALT Lymphoma)
Lead sponsor
International Extranodal Lymphoma Study Group (IELSG)
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2003
Completion date
February 17, 2016
Enrollment
454 (actual)
Sites
75

Conditions

As the registry lists them; a condition with its own page is linked.

lymphoma, mucosa-associated lymphoid tissue